SEK 47.64
Key Takeaways
Risk factor
Low price volatility
Profitability factor
Solid dividends
About
Elekta AB (publ), a medical technology company, provides clinical solutions for treating cancer and brain disorders worldwide. The company offers Versa HD, a brain metastases solution; Elekta Unity, a MR-Linac technology; Elekta Harmony, a linear accelerator; Elekta Infinity for treating a range of patients with simple-to-complex radiotherapy needs; Elekta Synergy, a digital accelerator for advanced...
Company Valuation
From both historical and forecast perspectives, the stock is moderately underpriced compared to similar stocks. In particular, the stock is reasonably priced on P/E, 'che
Target Price
The average target price of EKTA-B.ST is 50 and suggests 6% upside potential. Usually, this means a HOLD recommendation among investment firms. This neutral recommendatio
